MCR Oil Tools v. TRAN

Procedural entryThis page is a short order in MCR Oil Tools v. TRAN. Read the opinion of the Court — 102 F.4th 326
Court of Appeals for the Fifth Circuit·Decided June 12, 2024·No. 24-60230·Unpublished

Opinion

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit ____________ FILED June 12, 2024 No. 24-60230 ____________ Lyle W. Cayce Clerk MCR Oil Tools, L.L.C.,

Petitioner,

versus

United States Department of Transportation; Pete Buttigieg, Secretary, U.S. Department of Transportation; Pipeline and Hazardous Materials Safety Administration; William S. Schoonover, in his official capacity as Associate Administrator of Hazardous Materials Safety, Pipeline and Hazardous Materials Safety Administration,

Respondents. ______________________________

Petition for Review of an Order of the Department of Transportation, NTSB Agency No. 49 CFR 171-80 ______________________________

UNPUBLISHED ORDER MCR Oil Tools (“MCR”) seeks a stay pending review of an action of the Pipeline and Hazardous Materials Safety Administration (“PHMSA” or the “agency”) in which the agency determined that MCR could not lawfully transport—and therefore sell—a product accounting for most of its revenue. Because all four factors favor a stay, we GRANT MCR’s motion to stay the No. 24-60230

agency action pending expedited judicial review, noting that merits briefing is underway and that oral argument is scheduled for July 9, 2024.

I. MCR is a Texas-based manufacturer of advanced cutting systems for the pipe-recovery industry. Since 1993, it has produced the Radial Cutting Torch (“RCT”), “a family of tools that safely cut and perforate drill pipe, tubing, casing, and coiled tubing in ‘downhole’ conditions.” Ex.2 ¶ 2 (cleaned up). As the company’s flagship product, the RCT is MCR’s “pri- mary generator of revenue”—accounting for about 75% of its sales. Ex.2 ¶ 3. RCTs are primarily used in the oil and natural gas industry to remove “stuck pipes.” The tool functions by converting B15 mix—a proprietary thermite mixture—into highly energetic and focused plasma. Pipe-recovery operators channel that stream of plasma, much like a laser, to slice through below-grade pipe cleanly. RCTs are therefore a replacement for legacy detonation-based tools, which rupture stuck pipes with explosive charges. See Ex.2 ¶¶ 15–19.

II. The petition for review concerns PHMSA’s determination (the “RCT Action”) that MCR’s RCT is “an unapproved explosive that ‘shall not be offered for transportation or transported.’” Ex.1 at 5. That decision, however, relies on an earlier, independent PHMSA action (the “B15 Ac- tion”) classifying MCR’s B15 thermite mixture. So we briefly detail the agency’s determination in the B15 Action.

A. B15 Action In February 2022, PHMSA notified MCR that it had deemed B15 mix an “explosive” subject to regulation as a Division 4.1 flammable solid. Ex.D at 1. Then, in March 2022, PHMSA issued a revised determination. As

2 No. 24-60230

relevant here, the revision altered the February determination by adding B15 mix to Packing Group (PG) II. Ex.P. After unsuccessfully requesting reconsideration of the March deter- mination, see generally Ex.G, Ex.L, MCR appealed to the Deputy Adminis- trator, see generally Ex.E. PHMSA denied MCR’s appeal. See Ex.F at 9–10. But that was not all. In noticing the denial, PHMSA also accused MCR of knowingly shipping RCTs without the requisite “classification approval for the torch.” Ex.F at 8. Specifically, its warning stated that [b]ased on MCR’s appeal, it appears its device, the [RCT], has not been approved for transportation . . . even though MCR knows that a separate classification approval . . . is required. . . . Consequently, MCR should understand that it must take ap- propriate action, consistent with this decision, to ensure its [RCT] is offered for transportation in full compliance with the HMR. Ex.F at 8.

B. RCT Action After receiving that warning, MCR corresponded with the agency for approximately ten months—seeking to confirm, inter alia, that, absent sepa- rate approval by PHMSA, B15 mix could be shipped inside components of disassembled RCTs. See, e.g., Ex.N at 4. In MCR’s view, disassembled RCT components should be classified as “unrated,” or, in the alternative, as “a [Division] 4.1 flammable solid, packing group II.” Ex.G. at 1–2. PHMSA disagreed. In May 2024, it concluded that the RCT is “an article and a new explosive requiring its own approval.” Ex.1 at 2. Further, it found that “the RCT . . . is appropriately classified as a Class 1 explosive.” Ex.1 at 5. PHMSA ultimately determined that “the RCT [is] an unapproved explosive that ‘shall not be offered for transportation or transported’ pursu-

3 No. 24-60230

ant to 49 CFR § 173.54(a).” Ex.1 at 6.

C. Judicial Review MCR sought judicial review of, as relevant here, the RCT Action. 1 An administrative panel of this court granted its motion for expedited review. See generally Doc. 24-1. That panel ordered that MCR’s motions for stay pending review and for administrative stay be carried with the case, see id. at 2, the latter of which was granted by this merits panel, see Doc. 27-2 at 1.

III. A. Stay Pending Review The “issuance of a stay is left to the court’s discretion.” R.J. Reynolds Vapor Co. v. FDA, 65 F.4th 182, 188 (5th Cir. 2023) (quoting Nken v. Holder, 556 U.S. 418, 433 (2009)) (cleaned up). Four factors guide our evaluating requests for stays pending appeal or review: (1) whether the stay applicant has made a strong showing that he is likely to succeed on the merits; (2) whether the applicant will be irreparably injured absent a stay; (3) whether issuance of the stay will substantially injure the other parties interested in the proceeding; and (4) where the public interest lies.[ 2] “The first two factors . . . are the most critical,” R.J. Reynolds, 65 F.4th at 189 (cleaned up), and the latter two merge when the government is the party opposing the stay, see Nken, 556 U.S. at 435.

_____________________ 1 MCR separately challenged the B15 Action. That matter is before a different panel of this court and, as of May 30, 2024, has been held in abeyance pending resolution of the petition for review at hand. See MCR Oil Tools, LLC v. U.S. DOT, No. 23-60458, Doc. 46-2 at 1 (5th Cir. May 30, 2024). 2 SEC v. Barton, 79 F.4th 573, 581 (5th Cir. 2023) (quoting Nken, 556 U.S. at 434) (cleaned up).

4 No. 24-60230

B. Review of Agency Action The Administrative Procedure Act (“APA”) requires us to “set aside” agency actions that are “arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law.” Calumet Shreveport Refin., L.L.C. v. EPA, 86 F.4th 1121, 1133 (5th Cir. 2023) (quoting 5 U.S.C. § 706(2)(A)). So we must “scrutinize the record to determine whether the agency has ‘examine[d] the relevant data and articulate[d] a satisfactory explanation for its action including a rational connection between the facts found and the choice made.’” Id. (quoting Motor Vehicle Mfrs. Ass’n of U.S., Inc. v. State Farm Mut. Auto Ins. Co., 463 U.S. 29, 43 (1983) (cleaned up)). But we “may not supply a reasoned basis for the agency’s decision that the agency itself has not given.” Id. (cleaned up). Agency action that is “premised on reason- ing that fails to account for relevant factors or evinces a clear error of judg- ment” must be set aside “as arbitrary and capricious.” Id. (cleaned up).

IV. MCR has shown that it will likely succeed in its APA challenge to the RCT Action.

Free access — add to your briefcase to read the full text and ask questions with AI

MCR Oil Tools v. TRAN, (5th Cir. 2024).

MCR Oil Tools v. TRAN (MCR Oil Tools v. TRAN) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Nken v. Holder
556 U.S. 418 (Supreme Court, 2009)
Laclede Gas Company v. St. Charles County
713 F.3d 413 (Eighth Circuit, 2013)
Kisor v. Wilkie
588 U.S. 558 (Supreme Court, 2019)
Wages and White Lion Invst v. FDA
16 F.4th 1130 (Fifth Circuit, 2021)
Amin v. Mayorkas
24 F.4th 383 (Fifth Circuit, 2022)
State of Texas v. United States
40 F.4th 205 (Fifth Circuit, 2022)
R.J. Reynolds Vapor v. FDA
65 F.4th 182 (Fifth Circuit, 2023)
SEC v. Barton
79 F.4th 573 (Fifth Circuit, 2023)
Chamber of Com of the USA v. SEC
85 F.4th 760 (Fifth Circuit, 2023)
State of Texas v. Becerra
89 F.4th 529 (Fifth Circuit, 2024)